Understanding measles immunity in adults
Part of Infections clinical trials.
This study looks at how the immune system responds to measles infection or vaccination in adults. It may help explain why some people develop stronger immunity than others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have no known history of having measles or getting the MMR vaccine.
- You are willing to receive the MMR vaccine before a measles outbreak (for one group).
- You have not been diagnosed with any chronic disease.
- You are not taking medicines or have a condition that weakens your immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how children's immune systems respond to measles, comparing those who are protected to those who are not. It may help us understand why measles affects children differently, which could lead to better care.
This study looks at how well vaccines for respiratory viruses work in people with weakened immune systems. It may help doctors give better vaccine advice to patients like you.
This study tests whether changing the measles vaccine timing in 6-month-old children can reduce allergy risk and also help protect against unrelated infections. If your child is already up to date with routine vaccines, they may be eligible for a modified measles (MMR) schedule used in the trial.
This trial offers a measles vaccine to children who have not had full measles shots, timed around visits to a children’s hospital. It aims to see whether vaccinating children at these health care contacts helps improve protection against measles.
This study tests a combined vaccine that protects against measles, mumps, rubella, and chickenpox (varicella) in one shot. It's for healthy children who have already had their first dose of chickenpox and MMR vaccines, to see if this booster is safe and works well.
This study tests a combined one-shot vaccine for measles, mumps, rubella, and chickenpox in healthy children aged 4 to 6 who've already had their first shots. It aims to see if this new combination vaccine is as effective and safe as giving separate boosters.
Hear when a new MEASLES DISEASE trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.